Search filters

List of works by Mohammed Eslam

A Sequential Algorithm Combining ADAPT and Liver Stiffness Can Stage Metabolic-Associated Fatty Liver Disease in Hospital-Based and Primary Care Patients

scientific article published on 26 November 2020

A polymorphism in the Irisin-encoding gene (FNDC5) associates with hepatic steatosis by differential miRNA binding to the 3'UTR

article

A variant in the MICA gene is associated with liver fibrosis progression in chronic hepatitis C through TGF-β1 dependent mechanisms

scientific article published in Scientific Reports

ABIDE: an accurate predictive model of liver decompensation in patients with non-alcoholic fatty liver-related cirrhosis

scientific article published on 25 September 2020

ADAPT: An Algorithm Incorporating PRO-C3 Accurately Identifies Patients With NAFLD and Advanced Fibrosis

scientific article published on 01 March 2019

An aptamer-based drug delivery agent (CD133-apt-Dox) selectively and effectively kills liver cancer stem-like cells

scientific article published on 19 December 2020

Association between metabolic abnormalities and hepatitis C-related hepatocellular carcinoma

article published in 2012

Association of Serum Adipocytokines With Insulin Resistance and Liver Injury in Patients With Chronic Hepatitis C Genotype 4 ⬇️

scientific article published on November 1, 2012

Changes in adipocytokines and insulin sensitivity during and after antiviral therapy for hepatitis C genotype 4

scientific article published on March 1, 2012

Changes in insulin sensitivity and body weight during and after peginterferon and ribavirin therapy for hepatitis C

scientific article published on April 1, 2011

Cross-Linked Multimeric Pro-Peptides of Type III Collagen (PC3X) in Hepatocellular Carcinoma - A Biomarker That Provides Additional Prognostic Value in AFP Positive Patients

scientific article published on 09 November 2020

Detrimental effects of metabolic dysfunction-associated fatty liver disease and increased neutrophil-to-lymphocyte ratio on severity of COVID-19

scientific article published on 04 June 2020

Diverse impacts of the rs58542926 E167K variant in TM6SF2 on viral and metabolic liver disease phenotypes

scientific article published on 28 January 2016

FibroGENE: A gene-based model for staging liver fibrosis

scientific article published on 16 November 2015

Fibrosis Severity as a Determinant of Cause-Specific Mortality in Patients With Advanced Nonalcoholic Fatty Liver Disease: A Multi-National Cohort Study

scientific article published on 05 May 2018

From NAFLD to MAFLD: a "redefining" moment for fatty liver disease

scientific article published on 21 July 2020

GES: A validated simple score to predict risk of HCC in patients with HCV-GT4 associated advanced liver fibrosis after oral antivirals

scientific article published on 18 September 2020

Genetic contributions to NAFLD: leveraging shared genetics to uncover systems biology

scientific article published on 22 October 2019

Genetic variation in the TLL1 gene is not associated with fibrosis in patients with metabolic associated fatty liver disease

scientific article published on 11 December 2020

Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention

scientific article published on 20 September 2017

Hepatic steatosis in genotype 4 chronic hepatitis C patients: implication for therapy

scientific article published on November 2010

IFN-λ3, not IFN-λ4, likely mediates IFNL3-IFNL4 haplotype-dependent hepatic inflammation and fibrosis

scientific article published on 10 April 2017

IFNL3 genotype is associated with pulmonary fibrosis in patients with systemic sclerosis

scientific article published on 16 October 2019

IFNL3 polymorphisms predict response to therapy in chronic hepatitis C genotype 2/3 infection

scientific article published on 24 April 2014

Insulin resistance impairs viral dynamics independently of ethnicity or genotypes

scientific article published on March 2012

Insulin resistance predicts rapid virologic response to peginterferon/ribavirin combination therapy in hepatitis C genotype 4 patients

scientific article published on 16 March 2010

Interaction of IFNL3 with insulin resistance, steatosis and lipid metabolism in chronic hepatitis C virus infection

scientific article

Interferon Lambda and Liver Fibrosis

scientific article published on 22 April 2019

Interferon-λ rs12979860 genotype and liver fibrosis in viral and non-viral chronic liver disease.

scientific article

KLRG1+ natural killer cells exert a novel antifibrotic function in chronic hepatitis B

scientific article published on 21 March 2019

Liver Phenotypes of European Adults Heterozygous or Homozygous for Pi*Z Variant of AAT (Pi*MZ vs Pi*ZZ genotype) and Non-carriers

scientific article published on 03 May 2020

MAFLD identifies patients with significant hepatic fibrosis better than NAFLD

scientific article published on 30 September 2020

MAFLD: A consensus-driven proposed nomenclature for metabolic associated fatty liver disease

scientific article published on 07 February 2020

MBOAT7 rs641738 increases risk of liver inflammation and transition to fibrosis in chronic hepatitis C.

scientific article published on 15 September 2016

Macrophages in metabolic associated fatty liver disease

scientific article published on 01 April 2020

Metabolic associated fatty liver disease and cancer risk: causal role or epiphenomenon?

scientific article published on 01 December 2020

Myeloid cell deletion of Aryl hydrocarbon Receptor Nuclear Translocator (ARNT) induces non-alcoholic steatohepatitis

scientific article published on 04 December 2019

Patients with diabetes are at higher risk for severe illness from COVID-19

scientific article published on 13 May 2020

Pioglitazone improves virological response to peginterferon alpha-2b/ribavirin combination therapy in hepatitis C genotype 4 patients with insulin resistance

scientific article published on 16 November 2009

Polymorphisms in STAT4 are not associated with treatment response and spontaneous clearance of hepatitis C virus in europeans

scientific article published on 27 April 2016

Redefining fatty liver disease: an international patient perspective

scientific article published on 05 October 2020

Refining the role of epicardial adipose tissue in non-alcoholic fatty liver disease

scientific article published on 04 October 2019

Reply to: Correspondence on "A new definition for metabolic associated fatty liver disease: an international expert consensus statement": MAFLD: Moving from a concept to practice

scientific article published on 13 August 2020

Reply to: Suboptimal accuracy of GES score to stratify post SVR HCC risk in a single-center cohort of European cirrhotics

scientific article published on 06 November 2020

Reply to: correspondence regarding "A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement": Bringing evidence to the NAFLD-MAFLD debate

scientific article published on 12 September 2020

Risk of severe illness from COVID-19 in patients with metabolic dysfunction-associated fatty liver disease and increased fibrosis scores

scientific article published on 15 May 2020

Serum lipids and chronic hepatitis C genotype 4: interaction and significance ⬇️

scientific article published on January 1, 2012

TLL1 rs17047200 Increases the Risk of Fibrosis Progression in Caucasian Patients With Chronic Hepatitis C.

scientific article published on 6 October 2017

Thalidomide with peginterferon alfa-2b and ribavirin in the treatment of non-responders genotype 1 chronic hepatitis C patients: proof of concept ⬇️

scientific article published on December 1, 2011

The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease

scientific article published on 01 October 2020

The Epigenetic Drug Discovery Landscape for Metabolic-associated Fatty Liver Disease

scientific article published on 28 March 2020

The changing epidemiology of liver diseases in the Asia-Pacific region

article

The membrane-bound O-acyltransferase domain-containing 7 variant rs641738 increases inflammation and fibrosis in chronic hepatitis B.

scientific article published on 20 January 2017

The role of IFN in the development of NAFLD and NASH

article

The role of insulin resistance in HIV/hepatitis C virus-coinfected patients.

scientific article

Toward More Accurate Nomenclature for Fatty Liver Diseases

scientific article published on 31 May 2019

Type 2 Diabetes and Metformin Use Associate With Outcomes of Patients With Non-alcoholic Steatohepatitis-related, Child-Pugh A Cirrhosis

scientific article published on 07 May 2020

What Has the COVID-19 Pandemic Taught Us so Far? Addressing the Problem from a Hepatologist's Perspective

scientific article published on 11 April 2020

When a new definition overhauls perceptions of MAFLD related cirrhosis care

scientific article published on 01 December 2020

Paulina is supported by:

About Paulina

Help